Session » 4M125: Pediatric Rheumatology: Outcomes & Quality of Life (1920–1925)
- 4:30PM-6:00PM
-
Abstract Number: 1924
Assessing Psychosocial Needs in Juvenile Dermatomyositis Patients Across the United Kingdom
- 4:30PM-6:00PM
-
Abstract Number: 1923
Disability and Health-Related Quality of Life Outcomes in Patients with Systemic or Polyarticular Juvenile Idiopathic Arthritis Treated with Tocilizumab in Randomized Controlled Phase 3 Trials
- 4:30PM-6:00PM
-
Abstract Number: 1925
Discriminant and Predictive Ability of the Parent Version of the Juvenile Arthritis Disease Activity Score in Two Large Multination Cohorts of Patients with Juvenile Idiopathic Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 1922
Improvement in Hepatitis B Screening Prior to Initiation of Biologic Therapy in the Pediatric Rheumatology Clinic
- 4:30PM-6:00PM
-
Abstract Number: 1921
Parent-Reported Medication Side-Effects and Their Impact on Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry
- 4:30PM-6:00PM
-
Abstract Number: 1920
School Nurse Education for Juvenile Idiopathic Arthritis